Market Snapshot

• Market size: US $ 680 M (2023) → US $ 6.40 B (2032); 28.3 % CAGR.
• Modality mix 2032: CT, X‑ray/DR, MRI, Ultrasound, PET/Nuclear.
• Fastest modality growth: MRI, Ultrasound
• Applications: Early detection and workflow/efficiency dominate incremental spend.
• Revenue streams: Cloud/Pay‑per‑Use fastest growing.
• End‑use: Teleradiology fastest growing.

Competitve Landscape

Europe’s competitive field is bifurcating:

• Leaders leverage mature channels and early MDR compliance to lock in multi‑hospital, grant‑funded platform deals.
• Rising Stars chase double‑digit share through aggregator marketplaces but must clear MDR and scale support to graduate.
• Challenged players without evidence or funding face attrition as the EU AI Act tightens post‑market obligations.

Vendors that couple MDR‑ready portfolios with retrofit‑friendly pricing and marketplace reach will capture the lion’s share of Europe’s projected US $ 6.4 B imaging‑AI spend by 2032.

 

Sample Insights

Regulatory Velocity by Company – Europe

Europe’s adoption is rigorous but consistent. By 2032, the projected $6 B+ market is feasible, with major expansions after ~2026 once more AI solutions re-certify under the new MDR and intangible acceptance climbs. Radiology leadership expects AI to become a “must-have,” especially for screening programs and time-critical diagnoses, across the continent.

Siemens (3 new CE/MDR grants) and GE (2) led the 2023-24 filing sprint, while Philips and two pure plays (Lunit, Viz.ai) each logged two approvals. The median pure play managed only one new clearance, indicating that MDR’s documentation load is widening the gap between well-capitalized vendors and small start-ups.

Germany – End-Use Segments Review

1. Hospitals: still the anchor, share drifts lower

• Why large today: 1 900 public & private hospitals draw on Krankenhauszukunftsgesetz (KHZG) and Länder cap‑ex budgets for CT/MR AI retrofits and workflow suites.
• Why share erodes: By 2026 most KHZG projects are completed; incremental growth shifts to subscription renewals rather than new licenses, while outpatient segments accelerate.

2. Imaging Centers: fastest cap‑ex recyclers

• Private groups (Radiomed, Med360°, Conradia) and investor‑backed chains (RadNet, Evidia) expand MRI capacity and advertise “AI‑enhanced 24 h turnaround”.
• Fee‑for‑service model plus supplementary private insurance (Beihilfe/PKV) makes SaaS AI affordable; centers expect 15‑20 % throughput gain from DL‑recon and auto‑triage.

3. Teleradiology: breakout growth winner

• 24 % of German night‑time reads already outsourced (RöKo 2024 survey).
• AI‑triage & structured‑report NLP reduce per‑case read time by 25‑35 %; major hubs (Telepaxx, TMC Deutschland) adopt pay‑per‑study cloud AI hosted in AWS Frankfurt, driving 40 % CAGR.

4. Clinics & Specialists: steady but secondary

• Small orthopedic or cardiology practices install niche AI (auto‑EF, fracture detection) but overall imaging volume is ceded to large centers; budget constraints keep CAGR <26 %.

5. “Other” Institutions

• Bundeswehr hospitals, Fraunhofer institutes and EU‑funded pilots sustain mid‑20 % growth yet remain <6 % share.

ROE (Rest of Europe) – GTM Readiness

Pricing agility and regulatory readiness dominate: disparate GDP‑per‑capita and mixed GDPR/Swiss‑FADP rules require tiered price menus and meticulous compliance. Partnerships with EU hubs and marketplace channels follow. Demand‑gen is least critical—local pilots trump broad marketing. Vendors must budget for multi‑currency SaaS quoting and Notified‑Body engagement before scaling.

Report Details

• Title: Europe – AI‑assisted Medical Imaging Market (Markintel™ Pulse, 2025–2032)
• Publisher: Marketstrat Inc
• Publication date: August 2025
• Length / format: 88‑page PDF
• Price: Individual ($2,495) / Team ($3,495) / Enterprise ($4,495)
• Geographic scope: Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
• Modalities: CT, MRI, X‑ray/DR, Ultrasound, PET/Nuclear
• Clinical areas: Oncology, Neurology/Stroke, Cardiology, Respiratory/Lung, MSK/Ortho, General Diagnostic
• Applications: Early detection/triage; diagnostic accuracy & classification; workflow/efficiency; prognosis & treatment; image enhancement/dose; segmentation/feature extraction; integration across modalities
• Revenue streams: Hardware (factory‑attach CAPEX uplift), Software (fixed licenses incl. enterprise subscriptions), Service (implementation/validation/support), Cloud/Pay‑per‑Use (metered per‑scan)
• End‑use: Hospitals, Imaging Centers, Clinics, Teleradiology, Other providers
• Language: English (US)
• Delivery: Secure PDF download
• Returns: All sales are final once files are delivered; Marketstrat will clarify data or correct errors within 30 days.

Table of Contents

SECTION 1 | EXECUTIVE SUMMARY

What this Pulse Covers

Key Numbers Snapshot (Europe)

What’s Driving Europe’s Curve

Where the Value Pools Form

Country Outlook—Six Different Routes to Scale

Near‑term Watchlist (Next 12–18 Months)

What to do now (Insights → Action)

OEMs

Pure‑plays

Providers & Networks

Investors

SECTION 2 | RESEARCH METHODOLOGY

About this Pulse Report

Scope & Segmentation

Marketstrat’s “Insights → Action” Approach

Dual‑lens Architecture

Top‑down Market Funnel (Europe)

How it Works in the Model

Bottom‑up Attach‑rate Flow (Europe)

What we model for Each Country and Segment

Evidence Confidence — Density vs Reliability (Europe)

Reading the Bubbles

Regional Frameworks Included in this Pulse Report

GTM Country Tools

Quality Assurance & Governance

Limitations & Mitigations

SECTION 3 | EUROPEAN MARKET ANALYSIS

Market Overview & Analysis

Market Snapshot

Structural Demand Signals

Regulatory & Funding Landscape (2024-2028)

Market Segmentation 2032 (value share)

Competitive Heat Map (2024-26)

Execution Playbook (2024-2027)

Action-Oriented Recommendations

European Market Estimates and Forecasts by Country (2023-2032, USD Mill)

Five Forces Shaping Adoption

Country Archetypes & What Sells

Near‑term Adoption Runway (2024-27)

Strategic Implications

Regulatory Velocity by Company – Europe

Markintel Growth Maturity Matrix – Europe

Landscape Snapshot

Why the Quadrant Looks the Way it Does

Key Competitive Dynamics

Strategic Takeaways

Bottom Line

M&A Watchlist – Europe

Competitive Dataset – Europe

Growth & Maturity Highlights – Europe

Markintel Ecosystem Collaboration Matrix (ECM) – Europe

Quadrant Commentary & European Illustrations

Action Checklist

Markintel Solution Adoption & Growth Matrix – Europe

Quadrant Deep Dive

What Moves a Solution from One Box to the Next?

Strategic Guidance

AI Attach Rate – Europe

OEM AI Attach Rate

Attach Rate Trends – Europe

AI Revenue Split – Factory vs Retrofit Attach — Europe

GTM at a Glance – Europe

Channel & Pricing Matrix (2025-2028)

GTM Readiness Radar — Europe

Tiered Customer Landscape (2032 View)

GTM Timeline (2025 → 2028) – Europe

Adjacency Opportunity Radar (2026+) – Europe

Regulatory x Funding Heatmap – Europe

AI Imaging Whitespace Matrix – Europe

Fast Strategic Cues (2025 playbook)

SECTION 4 | GERMAN MARKET

Market Overview – Germany

Macro & Epidemiology

Health‑system & Funding Landscape

Regulatory & Evidence Pathway

Competitive Landscape

Strategic Takeaways & Recommendations

German Market by Clinical Area

Forecast by Clinical Area (2023-2032, USD Mill)

Primary Growth Catalysts

Strategic Messages for Stakeholders

Key Takeaways

German Market by Modality (2023-2032, USD Million)

Forecast by Modality (2023-2032, USD Mill)

Key Inflection by Modality

What’s Driving Each Modality

Strategic Implications

German Market by Revenue Stream (2023-2032, USD Million)

Forecast by Revenue Stream (2023-2032, USD Mill)

Revenue Streams and Drivers

Key Dynamics by Stream

Strategic Guidance

German Market by Clinical Application (2023-2032, USD Million)

Forecast by Clinical Application (2023-2032, USD Mill)

What is Driving Each Bucket

Strategic Messages

Action Playbook

German Market by End-Use Organization (2023-2032, USD Million)

Forecast by End-Use Organization (2023-2032, USD Mill)

Segments Review

Strategic Implications

German Market by AI Technology (2023-2032, USD Million)

Forecast by AI Technology (2023-2032, USD Mill)

Germany – AI Imaging Market by Core Technology

Why Deep Learning Keeps the Lion’s Share

Break-out Growth Themes

Strategic Playbook

GTM at-a-Glance – Germany

Channel x Pricing Matrix

GTM Readiness Radar — Germany

Tiered Customer Landscape

GTM Timeline – Germany

Fast Strategic Cues

SECTION 5 | FRENCH MARKET

Market Summary: France

Top‑line Snapshot – France

Key Market Dynamics

Strategic Takeaways

Top 3 Recommendations

French Market Speed scan – Market Analysis (2024‑2032)

French Market Estimates and Forecasts (2023-2032)

French Market by Clinical Area (2023-2032)

French Market by Modality (2023-2032)

French Market by Revenue Stream (2023-2032)

French Market by Clinical Application (2023-2032)

French Market by End-Use Organization (2023-2032)

French Market by AI Technology (2023-2032)

GTM at a Glance – France

Channel x Pricing Matrix

GTM Readiness Radar — What Counts Most in France

GTM Timeline (2024‑30) – France

Spend Potential by Customer Tier – France

SECTION 6 | UNITED KINGDOM MARKET

Market Overview – United Kingdom

UK Market Speed Scan

Scale & growth

Policy & funding

Demand triggers

Procurement routes

Competitive Field

Winning playbook 2024‑27

UK Market Estimates and Forecasts (2023-2032)

UK Market by Clinical Area (2023-2032)

UK Market by Modality (2023-2032)

UK Market by Revenue Stream (2023-2032)

UK Market by Clinical Application (2023-2032)

UK Market by End-Use Organization (2023-2032)

UK Market by AI Technology (2023-2032)

GTM at a Glance – UK

Channel x Pricing Matrix

GTM Readiness Radar – UK

Fast Strategic Cues

Tiered Customer Landscape – UK

GTM Timeline (2024‑29) – UK

SECTION 7 | ITALIAN MARKET

Market Overview & Summary: Italy

What Makes Italy Unique in the EU Context

Strategic Takeaways

Italian Market Estimates & Forecasts (2023-2032)

Italian Market by Clinical Area (2023-2032)

Italian by Modality (2023-2032)

Italian Market by Revenue Stream (2023-2032)

Italian Market by Clinical Application (2023-2032)

Italian Market by End-Use Organization (2023-2032)

Italian Market by AI Technology (2023-2032)

GTM at a Glance – Italy

Channel × Pricing Matrix

Tiered Customer Landscape & Spend Potential (2032) – Italy

GTM Readiness Radar – Italy

GTM Timeline (2024-29) – Italy

Fast Strategic Cues

SECTION 8 | SPANISH MARKET

Market Overview & Summary – Spain

Strategic Takeaways

Spanish Market Estimates and Forecasts (2023-2032)

Spanish Market by Clinical Area (2023-2032)

Spanish Market by Modality (2023-2032)

Spanish Market by Clinical Application (2023-2032)

Spanish Market by Revenue Stream (2023-2032)

Spanish Market by End-Use Organization (2023-2032)

Spanish Market by AI Technology (2023-2032)

GTM at a Glance – Spain

GTM Readiness Radar – Spain

Channel x Pricing Matrix

Tiered Customer Landscape – Spain

GTM Timeline – Spain

SECTION 9 |REST OF EUROPE (ROE) MARKET

Market Overview: Rest of Europe (ROE)

Size & trajectory

Why Growth Accelerates

Risks / Headwinds

Strategic Takeaways

Rest of European Market for AI in Medical Imaging (2023-2032)

Rest of European Market by Clinical Area (2023-2032)

Rest of European Market by Modality (2023-2032)

Rest of European Market by Revenue Stream (2023-2032)

Rest of European Market by Clinical Application (2023-2032)

Rest of European Market by End-Use Organization (2023-2032)

Rest of European Market by AI Technology (2023-2032)

GTM at a Glance – Rest of Europe (ROE)

GTM Readiness Radar – ROE

Tiered Customer Landscape – ROE

GTM Timeline – ROE

Channel × Pricing Matrix

Adjacency-Opportunity Matrix (2026-2030)

Country‑Cluster Framework & Strategic Playbook

White-Space Partnership Matrix

Regulatory Funding Heatmap (ROE Clusters)

Fast Strategic Cues

 

List of Tables

Table 1: AI Imaging Market by Country – Europe (2023—2032, USD Mill)

Table 2: German Market for AI in Medical Imaging by Clinical Area (2023-2032, USD Million)

Table 3: German Market for AI in Medical Imaging by Modality (2023-2032, USD Million)

Table 4: German Market for AI in Medical Imaging by Revenue Stream (2023-2032, USD Million)

Table 5: German Market for AI in Medical Imaging by Clinical Application (2023-2032, USD Million)

Table 6: German Market for AI in Medical Imaging by End-Use Organization (2023-2032, USD Million)

Table 7: German Market for AI in Medical Imaging by AI Technology (2023-2032, USD Million)

Table 8: French Market for AI in Medical Imaging by Clinical Area (2023-2032, USD Million)

Table 9: French Market for AI in Medical Imaging by Modality (2023-2032, USD Million)

Table 10: French Market for AI in Medical Imaging by Revenue Stream (2023-2032, USD Million)

Table 11: French Market for AI in Medical Imaging by Clinical Application (2023-2032, USD Million)

Table 12: French Market for AI in Medical Imaging by End-Use Organization (2023-2032, USD Million)

Table 13: French Market for AI in Medical Imaging by AI Technology (2023-2032, USD Million)

Table 14: UK Market for AI in Medical Imaging by Clinical Area (2023-2032, USD Million)

Table 15: UK Market for AI in Medical Imaging by Modality (2023-2032, USD Million)

Table 16: UK Market for AI in Medical Imaging by Revenue Stream (2023-2032, USD Million)

Table 17: UK Market for AI in Medical Imaging by Clinical Application (2023-2032, USD Million)

Table 18: UK Market for AI in Medical Imaging by End-Use Organization (2023-2032, USD Million)

Table 19: UK Market for AI in Medical Imaging by AI Technology (2023-2032, USD Million)

Table 20: Italian Market for AI in Medical Imaging by Clinical Area (2023-2032, USD Million)

Table 21: Italian Market for AI in Medical Imaging by Modality (2023-2032, USD Million)

Table 22: Italian Market for AI in Medical Imaging by Revenue Stream (2023-2032, USD Million)

Table 23: Italian Market for AI in Medical Imaging by Clinical Application (2023-2032, USD Million)

Table 24: Italian Market for AI in Medical Imaging by End-Use Organization (2023-2032, USD Million)

Table 25: Italian Market for AI in Medical Imaging by AI Technology (2023-2032, USD Million)

Table 26: GTM Readiness Radar – Italy

Table 27: Spanish Market for AI in Medical Imaging by Clinical Area (2023-2032, USD Million)

Table 28: Spanish Market for AI in Medical Imaging by Modality (2023-2032, USD Million)

Table 29: Spanish Market for AI in Medical Imaging by Clinical Application (2023-2032, USD Million)

Table 30: Spanish Market for AI in Medical Imaging by Revenue Stream (2023-2032, USD Million)

Table 31: Spanish Market for AI in Medical Imaging by End-Use Organization (2023-2032, USD Million)

Table 32: Spanish Market for AI in Medical Imaging by AI Technology (2023-2032, USD Million)

Table 33: Rest of Europe Market for AI in Medical Imaging by Clinical Area (2023-2032, USD Million)

Table 34: Rest of Europe Market for AI in Medical Imaging by Modality (2023-2032, USD Million)

Table 35: Rest of Europe Market for AI in Medical Imaging by Revenue Stream (2023-2032, USD Million)

Table 36: Rest of Europe Market for AI in Medical Imaging by Clinical Application (2023-2032, USD Million)

Table 37: Rest of Europe Market for AI in Medical Imaging by End-Use Organization (2023-2032, USD Million)

Table 38: Rest of Europe Market for AI in Medical Imaging by AI Technology (2023-2032, USD Million)

Table 39: Adjacency-Opportunity Matrix – ROE (2026-2030)

Table 40: White-Space Partnership Matrix – ROE

 

 

List of Figures

Figure 1: Top-Down Market Funnel – Europe

Figure 2: Bottom-up Attach Rate Flow (Europe)

Figure 3: Evidence Confidence (Europe Moel) – Density vs Reliability

Figure 4: Regulatory Velocity by Company – Europe

Figure 5: Markintel Growth Maturity Matrix – Europe

Figure 6: Markintel™ Ecosystem Collaboration Matrix (ECM) – Europe

Figure 7: Markintel Solution Adoption & Growth Matrix – Europe

Figure 8: OEM AI Attach Rate – Europe (2024)

Figure 9: AI Revenue Split – Factory vs Retrofit Attach — Europe (2024)

Figure 10: GTM Readiness Radar — Europe

Figure 11: Potential by Customer Tier – Europe (2032)

Figure 12: GTM Timeline (2025 → 2028) – Europe

Figure 13: Adjacency Opportunity Radar (2026+) – Europe

Figure 14: Regulatory x Funding Heatmap – Europe (2024)

Figure 15: AI Imaging Whitespace Matrix – Europe

Figure 16: GTM Readiness Radar — Germany

Figure 17: Projected Imaging AI Spend by Customer Tier – Germany (2032)

Figure 18: GTM Timeline – Germany

Figure 19: GTM Readiness Radar — What Counts Most in France

Figure 20: GTM Timeline (2024 30) – France

Figure 21: Spend Potential by Customer Tier – France (2032)

Figure 22: GTM Readiness Radar – UK

Figure 23: Spend Potential by Customer Tier – UK (2032)

Figure 24: GTM Timeline (2024 29) – UK

Figure 25: Tiered Customer Landscape & Spend Potential (2032)

Figure 26: GTM Readiness Radar – Italy

Figure 27: GTM Timeline (2024-29) – Italy

Figure 28: GTM Readiness Radar – Spain

Figure 29: Tiered Customer Landscape – Spain

Figure 30: GTM Timeline – Spain (2024-2029)

Figure 31: GTM at a Glance – Rest of Europe (ROE)

Figure 32: Tiered Customer Landscape – ROE (2032)

Figure 33: GTM Timeline – ROE

Figure 34: Regulatory Funding Heatmap (ROE Clusters)